Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment

Carla M L van Herpen, Ulrik Lassen, Ingrid M E Desar, Kathryn H Brown, Marcelo Marotti, Maja J A de Jonge

6 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab